On September 24, 2024, the Association of Cannabinoid Specialists hosted a paneled event surrounding the topic of policy and rescheduling, and what it means for patients and clinicians.
The format was a paneled discussion featuring three lawyers (Mark Bolton, Kristine Blackwood, Bryant Godfrey), a cannabinoid physician (Jordan Tishler, MD), and a moderator in front of a live audience reading questions submitted to ACS prior to the event.
The recurring themes throughout the questions were FDA regulation and what the future holds for cannabis patients, clinicians, and businesses if rescheduling happens. Right now, with so many unknown factors, our panel could only give us educated guesses based as to how this may play out and how rescheduling may affect cannabinoid medicine in both the short and long term.
Join the Association of Cannabinoid Specialists! For information on free student memberships or discounted memberships for recent graduates, email [email protected]